| Charles Phillip Schneider, MD | |
|
206 E Elm St, Caldwell, ID 83605-4815 | |
| (208) 459-4511 | |
| (208) 459-6602 |
| Full Name | Charles Phillip Schneider |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 206 E Elm St, Caldwell, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538158225 | NPI | - | NPPES |
| 003943100 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | M3796 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Phillip Schneider, MD 206 E Elm St, Caldwell, ID 83605-4815 Ph: (208) 459-4511 | Charles Phillip Schneider, MD 206 E Elm St, Caldwell, ID 83605-4815 Ph: (208) 459-4511 |
News Archive
Pay-for-performance reimbursement models may create unintended financial incentives for doctors to discriminate against obese patients, measuring a patient's waist circumference may be more effective in predicting surgical outcomes than the more traditional body mass index measure, and childhood obesity doubles the risk of developing colon cancer, according to data being presented at Digestive Disease Week- 2010.
Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570 (the "'570 Patent"), 7,297,346 (the "'346 Patent") and RE37,516 (the "'516 Patent") for the Cephalon product NUVIGIL® (armodafinil) Tablets [C-IV].
Just when we had all been convinced by information from just about every quarter, that fat was the bad guy of the diet kingdom, new research has found that a healthy dose of fat is needed for a healthy metabolism.
New York City has announced plans to ban the sale of sodas and other sugary beverages larger than 16 ounces in restaurants and entertainment venues. The Academy of Nutrition and Dietetics encourages consumers to be aware of how all beverages fit into their healthful daily eating plan.
The U.S. Food and Drug Administration today approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages 12 to 17. Harvoni and Sovaldi were previously approved to treat HCV in adults.
› Verified 3 days ago
Robert G Hansen, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 206 E Elm St, Caldwell, ID 83605 Phone: 208-459-4511 Fax: 208-459-6602 | |
George Arthur Nicola, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 206 E Elm St, Caldwell, ID 83605 Phone: 208-459-4511 Fax: 208-459-6602 | |
Craig R Jamison, PAC Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 206 E Elm St, Caldwell, ID 83605 Phone: 208-459-4511 Fax: 208-459-4511 | |
John Quentin Smith, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 206 E Elm St, Caldwell, ID 83605 Phone: 208-459-4511 Fax: 208-459-6602 | |
Michael T Daines, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 206 E Elm St, Caldwell, ID 83605 Phone: 208-459-4511 Fax: 208-459-6602 |